Literature DB >> 23122920

Age-related changes in neuroactive steroid levels in 3xTg-AD mice.

Donatella Caruso1, Anna M Barron, Meghan A Brown, Federico Abbiati, Paloma Carrero, Christian J Pike, Luis M Garcia-Segura, Roberto C Melcangi.   

Abstract

Although neuroactive steroids exert neuroprotective actions in different experimental models of neurodegenerative diseases, including those of Alzheimer's disease (AD), their relationships with aged related physiologic and pathologic brain changes remain to be clarified. In this study the levels of pregnenolone, dehydroepiandrosterone, progesterone, dihydroprogesterone, tetrahydroprogesterone, isopregnanolone, testosterone, dihydrotestosterone, 5α-androstane-3α,17β-diol, 5α-androstane-3β,17β-diol, 17α-estradiol, and 17β-estradiol were assessed in the limbic region of young adult (7 months) and aged (24 months) male wild type and triple transgenic AD mice. Age related neuropathological changes in AD brains, such as β-amyloid accumulation and gliosis, were associated with modified levels of specific neuroactive steroids and particularly with changes in the levels of progesterone and testosterone metabolites. The altered levels of neuroactive steroids in aged AD brains might impact on the activation of neuroprotective signaling mediated by classic and nonclassic steroid receptors, like the gamma-aminobuttyric acid (GABA)-A receptor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23122920      PMCID: PMC3545103          DOI: 10.1016/j.neurobiolaging.2012.10.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  51 in total

1.  Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Emily R Rosario; Jenna C Carroll; Salvatore Oddo; Frank M LaFerla; Christian J Pike
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

Review 2.  Neuroactive steroids: state of the art and new perspectives.

Authors:  R C Melcangi; L M Garcia-Segura; A G Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

Review 3.  Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection.

Authors:  Roberto Cosimo Melcangi; Luis Miguel Garcia-Segura
Journal:  Horm Behav       Date:  2009-06-12       Impact factor: 3.587

Review 4.  Actions of estrogens on glial cells: Implications for neuroprotection.

Authors:  María-Angeles Arevalo; María Santos-Galindo; María-José Bellini; Iñigo Azcoitia; Luis M Garcia-Segura
Journal:  Biochim Biophys Acta       Date:  2009-10-07

5.  Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.

Authors:  Véronique Schaeffer; Christine Patte-Mensah; Anne Eckert; Ayikoe G Mensah-Nyagan
Journal:  J Neurobiol       Date:  2006-07

6.  Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice.

Authors:  Tobias Bittner; Martin Fuhrmann; Steffen Burgold; Simon M Ochs; Nadine Hoffmann; Gerda Mitteregger; Hans Kretzschmar; Frank M LaFerla; Jochen Herms
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

7.  Age-related changes in serum and brain levels of androgens in male Brown Norway rats.

Authors:  Emily R Rosario; Lilly Chang; Tina L Beckett; Jenna C Carroll; M Paul Murphy; Frank Z Stanczyk; Christian J Pike
Journal:  Neuroreport       Date:  2009-11-25       Impact factor: 1.837

8.  Selective regulation of neurosteroid biosynthesis in human neuroblastoma cells under hydrogen peroxide-induced oxidative stress condition.

Authors:  V Schaeffer; C Patte-Mensah; A Eckert; A G Mensah-Nyagan
Journal:  Neuroscience       Date:  2007-12-03       Impact factor: 3.590

9.  Microglia-specific localisation of a novel calcium binding protein, Iba1.

Authors:  D Ito; Y Imai; K Ohsawa; K Nakajima; Y Fukuuchi; S Kohsaka
Journal:  Brain Res Mol Brain Res       Date:  1998-06-01

10.  Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease.

Authors:  Cassia R Overk; Christy M Kelley; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2009-06-12       Impact factor: 5.996

View more
  37 in total

Review 1.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 3.  Sex and the development of Alzheimer's disease.

Authors:  Christian J Pike
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

4.  Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice.

Authors:  Karin Sandoval; David Umbaugh; Austin House; Albert Crider; Ken Witt
Journal:  Neurochem Res       Date:  2019-10-19       Impact factor: 3.996

Review 5.  Astrocytes and synaptic plasticity in health and disease.

Authors:  A Singh; Wickliffe C Abraham
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

Review 6.  Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research.

Authors:  P Porcu; A M Barron; C A Frye; A A Walf; S-Y Yang; X-Y He; A L Morrow; G C Panzica; R C Melcangi
Journal:  J Neuroendocrinol       Date:  2016-02       Impact factor: 3.627

Review 7.  The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer's Disease.

Authors:  Milad Hasanpour; Alireza Nourazarian; Mohammad Hossein Geranmayeh; Masoud Nikanfar; Fatemeh Khaki-Khatibi; Reza Rahbarghazi
Journal:  Neuromolecular Med       Date:  2018-05-04       Impact factor: 3.843

8.  Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease.

Authors:  Anna M Barron; Luis M Garcia-Segura; Donatella Caruso; Anusha Jayaraman; Joo-Won Lee; Roberto C Melcangi; Christian J Pike
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

Review 9.  Liver X receptors, nervous system, and lipid metabolism.

Authors:  G Cermenati; E Brioschi; F Abbiati; R C Melcangi; D Caruso; N Mitro
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

Review 10.  Neuroactive Steroids and Sex-Dimorphic Nervous Damage Induced by Diabetes Mellitus.

Authors:  Silvia Giatti; Silvia Diviccaro; Roberto Cosimo Melcangi
Journal:  Cell Mol Neurobiol       Date:  2018-08-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.